- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - Lynparza approved in EU for the treatment of germl
AnnouncementREG - AstraZeneca PLC Investor AB - Holding(s) in Company
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - FTSE Russell AstraZeneca PLC - Astrazeneca
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Selumetinib gets Breakthrough Therapy Designation
AnnouncementREG - AstraZeneca PLC - Results of Placing
AnnouncementREG - AstraZeneca PLC - AZ and Daiichi Sankyo enter collaboration in novel
AnnouncementREG - AstraZeneca PLC - Proposed placing of new ordinary shares
AnnouncementREG - AstraZeneca PLC - Forxiga approved in Japan for type-1 diabetes
AnnouncementREG - AstraZeneca PLC - Forxiga approved in Europe for type-1 diabetes
AnnouncementREG - AstraZeneca PLC - US FDA grants saracatinib ODD for IPF
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - Circassia Pharma Plc AstraZeneca PLC - Holding(s) in Company
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
Announcement